跳至主要内容
临床试验/CTRI/2023/05/052944
CTRI/2023/05/052944尚未招募2 期

Clinical Efficacy of Habb Mujarrab in Shaqeeqa (Migraine without aura)- A Randomized Single Blind Placebo Controlled Clinical Trial

ational Institute of Unani Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Diagnosed cases of Migraine without Aura (as per the International Classification of Headache Disorders (ICHD-3) with history for at least one year
  • 2.Patients between the age of 18â??50 years
  • 3.Patients of any gender
  • 4. Patients who will give consent and are able to do follow up

排除标准

  • 1.Headache other than Migraine without Aura
  • 2.Use of any migraine prophylactic agents (b-blockers, anti-depressants, calcium channel blockers, anti-epileptic agents, cycle-modulating hormonal drugs, or vessel dilatation agents) within 1 month prior to screen
  • 3.History or evidence of psychiatric disorder
  • 4.Patients with a score of 19 or higher on the Beck Depression Inventory-II (BDI-II)
  • 5.History of any systemic illness
  • 6.Pregnant and lactating women

研究者

发起方
ational Institute of Unani Medicine

相似试验